Publications library

This crowd-sourced list of publications related to the economics of immunization will be updated periodically. We rely on community members (YOU!) to share their materials with the broader Immunization Economics community of practice. To include your articles, papers, presentations, and other contents, please submit here

Last updated Feb 2019 by Christian Suharlim


Allison Portnoy, Mark Jit, Matthew Ferrari, Matthew Hanson, Logan Brenzel, Stéphane Verguet, (2019), Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis, The Lancet Global Health, [link]

Kimberly M Thompson, (2019), What will it take to end fatalities from measles?, The Lancet Global Health, [link]

Immunization Economics Community of Practice, (2019), How to cost immunization programs: a practical guide on primary data collection and analysis,, [link]

Kaslow, D.C., Black, S., Bloom, D.E., Dalta, M., Salisbury, D., Rappuoli, R., (2018), Vaccine candidates for poor nations are going to waste, Nature, 564(7736), 337-339., [link]

Bloom, D.E., Black, S., Salisbury, D., Rappuoli, R, (2018), Antimicrobial resistance and the role of vaccines, PNAS, [link]

Sevilla, J.P., Bloom, D.E., Cadarette, D., Jit, M., Lipsitch, M., (2018), Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR, PNAS, [link]

WHO, (2018), WHO resource guide: Working together, WHO, [link]

WHO, (2018), 2018 Assessment report of the Global Vaccine Action Plan, WHO, [link]

Kelsey Vaughan, Michaela Mallow, Annette Ozaltin, Logan Brenzel, (2018), Using cost evidence to achieve immunization programs that deliver for all: findings on the cost of delivering vaccines in low- and middle- income countries, Health Systems Research, Liverpool, [link]

Abt associates, (2018), Immunization and the Role of the Private Sector, Abt associates, [link]

Abt Associates, (2018), Investing Wisely to Improve Child Survival, Abt Associates, [link]

Abt Associates, (2018), Improving Immunization Programming in Mozambique: Insights from Health Expenditure Analysis, Abt Associates, [link]

Bloom, D.E., Cadarette, D., Sevilla, JP., (2018), Epidemics and Economics: Managing the Risks, Finance & Development, 55(2), 46-49. , [link]

Resch S, Hecht R, (2018), Transitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research, JOGH , [link]

Bloom DE, Fan VY, Sevilla, JP, (2018), The broad socioeconomic benefits of vaccination, Science Translational Medicine, [link]

UNICEF, (2018), Immunization Financing in MENA Middle-Income COuntries, UNICEF, [link]

Claudia L Rivera-Rodriguez, Stephen Resch, Sebastien Haneuse, (2018), Reducing statistical uncertainty in costing studies, SAGE Open Medicine, [link]

Riumallo-Herl C, Chang AY, Clark S, et al., (2018), Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study, BMJ Glob Health 2018;3:e000613., [link]

Chang AY, Riumallo-Herl C, Perales NA, et al, (2018), The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries, Health Affairs, [link]

Bloom, D.E., Fan, V.Y., & Sevilla, J.P., (2018), The broad socioeconomic benefits of vaccination, Science Translational Medicine, Vol. 10, Issue 441, eaaj2345., [link]

Chatterjee S, Das P, Nigam A, et al, (2018), Variation in cost and performance of routine immunisation service delivery in India, BMJ Global Health 2018;3:e000794., [link]

Natalie Carvalho, Mark Jit, Sarah Cox, Joanne Yoong, Raymond C. W. Hutubessy, (2018), Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework, PharmacoEconomics, [link]

Levine O., (2017), The Full Course Argument For Investing In Vaccines, Huffington Post, [link]

Siobhan Botwright, Taylor Holroyd, Shreya Nanda, Paul Bloem, Ulla K. Griffiths, Anissa Sidibe, Raymond C. W. Hutubessy , (2017), Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects, PLOS ONE, [link]

Lambach P, (2017), Economic value chain analysis for Influenza, WHO, [link]

Fangli Geng, Christian Suharlim, Logan Brenzel, Stephen C Resch, Nicolas A Menzies, (2017), The cost structure of routine infant immunization services: a systematic analysis of six countries, Health Policy & Planning, [link]

HPP, (2017), PODCAST: The cost structure of routine infant immunization services: a systematic analysis of six countries, Health Policy & Planning, [link]

GHCC, (2017), GHCC Reference Case for Global Health Costing , GHCC, [link]

Suharlim C., (2017), Injecting a business perspective into routine immunization programs, Health Policy and Planning, [link]

Robert Steinglass, (2017), Vaccines Don't Deliver Themselves, VOVRN, [link]

Nicolas A. Menzies, Christian Suharlim, Fangli Geng, Zachary J. Ward, Logan Brenzel and Stephen C. Resch, (2017), The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies, BMC Medicine, [link]

PAHO, (2017), ProVac decision-support e-toolkit launched, PAHO, [link]

R4D, (2017), Immunization Financing: A Resource Guide for Advocates, Policymakers, and Program Managers., R4D, [link]

Bloom DE, Brenzel L, Cadarette D, Sullivan J, (2017), Moving beyond traditional valuation of vaccination: Needs and opportunities, Vaccine, [link]

Levin, C., (2016), Meeting Report: Convening on immunization delivery costs, University of Washington, [link]

Bloom, D., Cadarette, D., Sullivan, J., (2016), Workshop Summary: Advancing the Value of Vaccines Research Agenda, Harvard University, [link]

Suharlim, C., Munk, C., Brenzel, L., Resch, S., (2016), Meeting Report: 2016 Immunization Costing Workshop, Harvard University, [link]

Harvard T.H. Chan School of Public Health, (2016), Helping nations assess and manage immunization costs. , Harvard T.H. Chan School of Public Health, [link]

Kinghorn, A., Schütte, C., Undi, M., Banda, S., (2016), Incorporating costing study results into district and service planning to enhance program performance - a Zambian Case Study , SDC, [link]

Bloom, D., Johnson, S., Cadarette, D., Sullivan, J., (2016), Workshop Pre-reading: Advancing the Value of Vaccines Research Agenda, Harvard University, [link]

Brenzel, L, (2016), Vaccines: The Best Shot for Children and Economies., Impatient Optimists, [link]

Rikken, M., (2016), Vaccines save up to 44 dollars to the dollar, Researchgate, [link]

Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D., (2016), Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20. , Health Affairs,35, 199-207., [link]

Brenzel, L., Schütte, C., Goguadze, K., Valdez, W., Gargasson, J., & Guthrie, T., (2016), EPIC Studies: Governments Finance, On Average, More Than 50 Percent Of Immunization Expenses, 2010–11, Health Affairs,35, 259-265., [link]

Griffiths, U.K., Bozzani, F.M., Chansa, C., Kinghorn, A., Goguadze, K., Kalesha-Masumbu, P., Rudd, C., Chilengi, R., Brenzel, L., & Schutte, C., (2016), Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?, Vaccine, [link]

Clift J, Arias D, Chaitkin M, O'Connell M, (2016), Landscape Study — The Cost, Impact, and Efficiency of Above Service Delivery Activities in HIV and Other Global Health Programs, R4D, [link]

Kinghorn, A., Schutte, C., Marinda, E., & Chansa, C, (2015), What drives Productivity and Costs of Routine Immunization Services in Zambia? , IHEA World Congress in Bocconi University, Milan., [link]

Janusz, C., Castaneda, C., Berenice, I.M., & Resch, S. , (2015), Cost and Productivity of Routine Immunization Services in Honduras, IHEA World Congress in Bocconi University, Milan., [link]

Resch, S., Lee, K., Suharlim, C., Ward, W., & Menzies, N., (2015), Estimating the costs of scaling up immunization: evidence from the EPIC studies, IHEA World Congress in Bocconi University, Milan., [link]

Menzies, N., Ward, Z., Suharlim, C., & Resch, S., (2015), Estimating the Technical Efficiency of Immunization Programs: Evidence from the EPIC Studies, IHEA World Congress in Bocconi University, Milan, [link]

PAHO, (2015), New studies show immunization remains a 'best buy' in the fight against vaccine-preventable diseases., PAHO, [link]

Andrus, J., & Walker, D., (2015), Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses, Vaccine, [link]

Brenzel, L., Young, D., & Walker, D., (2015), Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC), Vaccine, [link]

Gargasson, J., Nyonator, F., Adibo, M., Gessner, B., & Colombini, A., (2015), Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana, Vaccine, 33(Supplement I), A40-A46., [link]

Schütte, C., Chansa, C., Marinda, E., Guthrie, T., Banda, S., Nombewu, Z., . . . Kinghorn, A., (2015), Cost analysis of routine immunisation in Zambia, Vaccine, 33(Supplement 1), A47-A52. , [link]

Janusz, C., Castañeda-Orjuela, C., Aguilera, I., Garcia, A., Mendoza, L., Díaz, I., & Resch, S., (2015), Examining the cost of delivering routine immunization in Honduras, Vaccine, 33(Supplement I), A53-A59. , [link]

Goguadze, K., Chikovani, I., Gaberi, C., Maceira, D., Uchaneishvili, M., Chkhaidze, N., & Gotsadze, G., (2015), Costs of routine immunization services in Moldova: Findings of a facility-based costing study, Vaccine,33(Supplement I), A60-A65, [link]

Ahanhanzo, C., Huang, X., Gargasson, J., Sossou, J., Nyonator, F., Colombini, A., & Gessner, B., (2015), Determinants of routine immunization costing in Benin and Ghana in 2011, Vaccine,33(Supplement I), A66-A71. , [link]

Maceira, D., Goguadze, K., & Gotsadze, G., (2015), The drivers of facility-based immunization performance and costs. An application to Moldova., Vaccine, 33(Supplement I), A72-A78. , [link]

Guthrie, T., Zikusooka, C., Kwesiga, B., Abewe, C., Lagony, S., Schutte, C., . . . Kinghorn, A., (2015), Mapping financial flows for immunisation in Uganda 2009/10 and 2010/11: New insights for methodologies and policy., Vaccine, 33(Supplement I), A79-A84. , [link]

Valdés, W., Janusz, C., Aguilera, I., Mendoza, L., Díaz, I., & Resch, S., (2015), Tracking financial flows for immunization in Honduras, Vaccine,33(Supplement 1), A85–A92. , [link]

Brenzel, L., (2015), What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?, Vaccine, 33(Supplement I), A93-A98, [link]

additional resources: